Tilray Extraction EU
About Tilray Extraction EU
Tilray's European extraction facility in Portugal produces EU-GMP certified cannabis extracts and oils for distribution across European medical cannabis markets.
Key Facts
- 1Operates an EU-GMP certified cannabis cultivation and extraction facility in Cantanhede, Portugal
- 2Supplies medical cannabis extracts to pharmacies across Germany, Italy, and other European markets
Latest News
Tilray's Multi-Sector Bet Tests Cannabis Investor Patience
TLRY's expansion beyond cannabis into alcohol and wellness creates revenue diversification but raises questions about capital allocation efficiency and core competency focus.
Tilray's Beverage Expansion Tests Cannabis Diversification Playbook
TLRY's alcohol portfolio now generates more revenue than cannabis operations, marking a strategic pivot that challenges traditional sector valuations.
Frequently Asked Questions
Why did Tilray choose Portugal for European extraction?
Portugal offers favorable climate for cannabis cultivation, competitive operating costs, and EU membership enabling export of GMP-certified products across European medical markets.
What EU markets does Tilray supply?
Tilray's Portuguese facility supplies medical cannabis extracts primarily to Germany, the largest European medical cannabis market, as well as Italy, Poland, and other EU countries.
More Cannabis Companies in Cantanhede
Cannabis Laws
Products
- EU-GMP Cannabis Oils
- Medical Cannabis Extracts
- Standardized Cannabinoid Products
Specialties
Company Details
- Type
- Extraction
- Location
- Cantanhede, Portugal
- Founded
- 2017
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY